|
Supplier News Breaks Archives Watson Pharmaceuticals next year plans to roll out a chewable, low-dose oral contraceptive that the company called a new option for birth control. Novartis has received approval from the Food and Drug Administration for Amturnide tablets for the treatment of high blood pressure. Abbott Diabetes Care has begun a recall of 359 lots of various brands of blood glucose test strips in the United States and Puerto Rico. Olay has introduced the Olay Professional Pro-X Advanced Cleansing System, which the Procter & Gamble Co. skin care brand said is first at-home facial cleansing tool that cleans and exfoliates as effectively as a professional cleansing system. Emisphere Technologies Inc. and Novo Nordisk A/S have teamed up to develop oral formulations of insulin for diabetes. The Pharmaceutical Research and Manufacturers of America (PhRMA) this week announced the election of four new members to its board of directors. Manchester College in northern Indiana has received a $35 million grant from Lilly Endowment to launch a school of pharmacy. Amneal Enterprises LLC has expanded into the dermatology market with the addition of Quinnova Pharmaceuticals Inc. as an independent affiliate. Tom's of Maine is encouraging mobile dental clinics nationwide to apply for $20,000 in program funding as part of its annual Dental Health For All program.
|
